A 5-year follow-up of self-expanding metal stents in the endoscopie management of patients with benign bile duct strictures

1998 ◽  
Vol 10 (2) ◽  
pp. 141-146 ◽  
Author(s):  
Sharon M. OʼBrien ◽  
Adrian R.W. Hatfield ◽  
Philip I. Craig ◽  
Steven P. Williams
2021 ◽  
Vol 09 (09) ◽  
pp. E1386-E1390
Author(s):  
Morgan Wong ◽  
Sergio A. Sánchez-Luna ◽  
Tarun Rustagi

Abstract Background and study aims Fully covered self-expanding metal stents (FCSEMS) are being increasingly used for benign biliary strictures (BBS); however, they are associated with risk of acute cholecystitis. Prophylactic endoscopic transpapillary gallbladder stenting (ETPGBS) can facilitate continuous gallbladder drainage and prevent acute cholecystitis from occlusion of cystic duct orifice by the FCSEMS. The aim of this study was to assess the technical feasibility, efficacy, and safety of ETPGBS to prevent acute cholecystitis in patients receiving FCSEMS for BBS. Patients and methods This was a retrospective analysis of a prospectively collected database at a single center of all patients who underwent prophylactic ETPGBS with FCSEMS for BBS between December 1, 2016 and November 30, 2020. Results A total of 71 ETPGBS were placed during the study period. Sixteen patients (mean age: 66.4 ± 19.8 years; 81 % male) underwent ETPGBS prior to biliary FCSEMS during the same endoscopic session. FCSEMS were left in place (stent dwell time) for a median of 173 days (range: 69–473; mean 196 ± 121) with resolution of BBS and successful removal of ETPGBS and FCSEMS in 12 patients. There was significant improvement in total bilirubin level (5.25 ± 5.53 vs 0.94 ± 0.85 gm/dL; P = 0.008). No episodes of acute cholecystitis or any other post-procedural complications were noted during the median follow-up of 337 days (range: 150–856; mean 394 ± 236). Conclusions ETPGBS prevented stent-related acute cholecystitis with continued efficacy of FCSEMS for BBS.


2021 ◽  
Vol 26 (4) ◽  
pp. 248-253
Author(s):  
Gunn Huh ◽  
Tae Jun Song

Endoscopic ultrasound (EUS)-guided transmural drainage of peripancreatic fluid collection, gallbladder, bile duct, or pancreatic duct has emerged as a therapeutic option in patients with pancreatobiliary diseases. Recently, dedicated stents for EUS-guided interventions, which include lumen-apposing metal stents and modified tubular self-expanding metal stents, have been developed to improve efficacy and safety of these procedures. This article has reviewed newly developed stents for EUSguided interventions and their therapeutic outcomes.


2013 ◽  
Vol 105 (1) ◽  
pp. 7-12 ◽  
Author(s):  
Jesús García-Cano ◽  
Amanda Karolina Reyes-Guevara ◽  
Teresa Martínez-Pérez ◽  
Laura Valiente-González ◽  
Raquel Martínez-Fernández ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Ahmed Abdel Samie ◽  
Lorenz Theilmann

Transpapillary stents are increasingly being used for biliary strictures, whether benign or malignant. However, there are different stent types and available data is controversial. Recently, completely covered self-expandable metal stents (CSEMSs) have been proposed as an alternative therapeutic option in different biliary indications, including strictures of the distal bile duct, anastomotic stenosis after orthotopic liver transplantation, bile duct leaks, periampullary perforation following endoscopic sphincterotomy (ES), and postsphincterotomy bleeding. Despite the higher costs of these devices, fully covered self-expanding metal stents seem to be a suitable therapeutic option to relief biliary obstruction due to bile duct stenosis, regardless of the underlying cause.


2010 ◽  
Vol 71 (5) ◽  
pp. AB162
Author(s):  
Timothy M. Schmitt ◽  
Patricia L. Foley ◽  
Indu Srinivasan ◽  
Jeremy J. Gatesman ◽  
Michele E. Rehan ◽  
...  

2019 ◽  
Vol 07 (11) ◽  
pp. E1419-E1423 ◽  
Author(s):  
Reem Z. Sharaiha ◽  
Aleksey Novikov ◽  
Kristen Weaver ◽  
Pawan Marfatia ◽  
Jonathan M. Buscaglia ◽  
...  

Abstract Background and study aims Fully covered self-expanding metal stents (FCSEMS) have been used to treat refractory pancreatic duct strictures. We aimed to evaluate the feasibility, safety, and efficacy of FCSEMS in chronic pancreatitis with refractory pancreatic duct strictures. Patients and methods This was a retrospective multicenter cases series of patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) with FCSEMS placement in the main pancreatic duct (MPD) at five tertiary care centers between February 2010 and June 2016. Primary endpoints were technical success, clinical success, and procedure-related morbidity. Secondary endpoints were pain relief at the end of follow-up and resolution of the pancreatic stricture on ERCP. Results Thirty-three patients with previously drained stents, 76 % of whom were male, underwent ERCP with FCSEMS placement. Mean duration of follow-up was 14 months. All of the patients had prior therapy. The technical success rate for FCSEMS placement was 100 % (n = 33) and the clinical success rate was 93 % (was n = 31). Stents were removed after a median duration of 14.4 weeks. After stent removal, the diameter of the narrowest MPD stricture had increased significantly from 1 mm to 4.5 mm (P < 0.001). There was a statistically significant improvement on the Visual Analogue Scale (VAS) from a median of 8.5 to 2.5. At the end of the study, (n = 27) 87.1 % of patients reported significant pain reduction with reduced narcotic use. Conclusion FCSEMS appeared to be a feasible, safe, and potentially effective Intervention in patients who had not responded to endoscopic therapy with plastic stents.


2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Mihir R Bakhru ◽  
Patricia L Foley ◽  
Jeremy Gatesman ◽  
Timothy Schmitt ◽  
Christopher A Moskaluk ◽  
...  

2018 ◽  
Vol 06 (07) ◽  
pp. E902-E906 ◽  
Author(s):  
Reiner Köck ◽  
Christian Jürgensen ◽  
Rupert Fischer-Lampsatis

Abstract Background and study aims Endoscopic ultrasound (EUS)-guided drainage is a well-established procedure for peripancreatic fluid collections (PFC) that develop in the context of acute pancreatitis or following pancreatic surgery. Malignant ascites can occur in a loculated form resembling PFC causing a variety of symptoms, with limited treatment options. There is a paucity of data about application of EUS-guided drainage for these kinds of fluid collections. So far, only one report exists describing clinical success in three cases, using fully-covered self-expanding metal stents (FCSEMS). FCSEMS, however, have possible drawbacks, particularly if they have to remain in place for an indeterminate period of time. Herein, we describe EUS-guided drainage of loculated malignant ascites using double-pigtail plastic stents in two patients severely symptomatic from esophagogastric obstruction symptoms. Technical and clinical success was achieved in both cases without clinically significant complications including one case, where ongoing symptom control could be observed after 6 months of follow-up.


Sign in / Sign up

Export Citation Format

Share Document